Cargando…

Solute removal during continuous renal replacement therapy in critically ill patients: convection versus diffusion

INTRODUCTION: The best modality, for continuous renal replacement therapy (CRRT) is currently uncertain and it is poorly understood how transport of different solutes, whether convective or diffusive, changes over time. METHODS: We conducted a prospective cross over study in a cohort of critically i...

Descripción completa

Detalles Bibliográficos
Autores principales: Ricci, Zaccaria, Ronco, Claudio, Bachetoni, Alessandra, D'amico, Giuseppe, Rossi, Stefano, Alessandri, Elisa, Rocco, Monica, Pietropaoli, Paolo
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1550874/
https://www.ncbi.nlm.nih.gov/pubmed/16646985
http://dx.doi.org/10.1186/cc4903
_version_ 1782129293427474432
author Ricci, Zaccaria
Ronco, Claudio
Bachetoni, Alessandra
D'amico, Giuseppe
Rossi, Stefano
Alessandri, Elisa
Rocco, Monica
Pietropaoli, Paolo
author_facet Ricci, Zaccaria
Ronco, Claudio
Bachetoni, Alessandra
D'amico, Giuseppe
Rossi, Stefano
Alessandri, Elisa
Rocco, Monica
Pietropaoli, Paolo
author_sort Ricci, Zaccaria
collection PubMed
description INTRODUCTION: The best modality, for continuous renal replacement therapy (CRRT) is currently uncertain and it is poorly understood how transport of different solutes, whether convective or diffusive, changes over time. METHODS: We conducted a prospective cross over study in a cohort of critically ill patients, comparing small (urea and creatinine) and middle (β(2 )microglobulin) molecular weight solute clearance, filter lifespan and membrane performance over a period of 72 hours, during 15 continuous veno-venous dialysis (CVVHD) and 15 continuous veno-venous hemofiltration (CVVH)sessions. Both modalities were administered based on a prescription of 35 ml/kg/h and using polyacrylonitrile filters. RESULTS: Median filter lifespan was significantly longer during CVVHD (37 hours, interquartile range (IQR) 19.5 to 72.5) than CVVH (19 hours, IQR 12.5 to 28) (p = 0.03). Median urea time weighted average (TWA) clearances were not significantly different during CVVH (31.6 ml/minute, IQR 23.2 to 38.9) and CVVHD (35.7 ml/minute, IQR 30.1 to 41.5) (p = 0.213). Similar results were found for creatinine: 38.1 ml/minute, IQR 28.5 to 39, and 35.6 ml/minute, IQR 26 to 43 (p = 0.917), respectively. Median β(2)m TWA clearance was higher during convective (16.3 ml/minute, IQR 10.9 to 23) than diffusive (6.27 ml/minute, IQR 1.6 to 14.9) therapy; nonetheless this difference did not reach statistical significance (p = 0.055). Median TWA adsorptive clearance of β(2)m appeared to have scarce impact on overall solute removal (0.012 ml/minute, IQR -0.09 to 0.1, during hemofiltration versus -0.016 ml/minute, IQR -0.08 to 0.1 during dialysis; p = 0.79). Analysis of clearance modification over time did not show significant modifications of urea, creatinine and β(2)m clearance in the first 48 hours during both treatments. In the CVVHD group, the only significant difference was found for β(2)m between 72 hours and baseline clearance. CONCLUSION: Polyacrylonitrile filters during continuous hemofiltration and continuous hemodialysis delivered at 35 ml/kg/h are comparable in little and middle size solute removal. CVVHD appears to warrant longer CRRT sessions. The capacity of both modalities for removing such molecules is maintained up to 48 hours.
format Text
id pubmed-1550874
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-15508742006-08-22 Solute removal during continuous renal replacement therapy in critically ill patients: convection versus diffusion Ricci, Zaccaria Ronco, Claudio Bachetoni, Alessandra D'amico, Giuseppe Rossi, Stefano Alessandri, Elisa Rocco, Monica Pietropaoli, Paolo Crit Care Research INTRODUCTION: The best modality, for continuous renal replacement therapy (CRRT) is currently uncertain and it is poorly understood how transport of different solutes, whether convective or diffusive, changes over time. METHODS: We conducted a prospective cross over study in a cohort of critically ill patients, comparing small (urea and creatinine) and middle (β(2 )microglobulin) molecular weight solute clearance, filter lifespan and membrane performance over a period of 72 hours, during 15 continuous veno-venous dialysis (CVVHD) and 15 continuous veno-venous hemofiltration (CVVH)sessions. Both modalities were administered based on a prescription of 35 ml/kg/h and using polyacrylonitrile filters. RESULTS: Median filter lifespan was significantly longer during CVVHD (37 hours, interquartile range (IQR) 19.5 to 72.5) than CVVH (19 hours, IQR 12.5 to 28) (p = 0.03). Median urea time weighted average (TWA) clearances were not significantly different during CVVH (31.6 ml/minute, IQR 23.2 to 38.9) and CVVHD (35.7 ml/minute, IQR 30.1 to 41.5) (p = 0.213). Similar results were found for creatinine: 38.1 ml/minute, IQR 28.5 to 39, and 35.6 ml/minute, IQR 26 to 43 (p = 0.917), respectively. Median β(2)m TWA clearance was higher during convective (16.3 ml/minute, IQR 10.9 to 23) than diffusive (6.27 ml/minute, IQR 1.6 to 14.9) therapy; nonetheless this difference did not reach statistical significance (p = 0.055). Median TWA adsorptive clearance of β(2)m appeared to have scarce impact on overall solute removal (0.012 ml/minute, IQR -0.09 to 0.1, during hemofiltration versus -0.016 ml/minute, IQR -0.08 to 0.1 during dialysis; p = 0.79). Analysis of clearance modification over time did not show significant modifications of urea, creatinine and β(2)m clearance in the first 48 hours during both treatments. In the CVVHD group, the only significant difference was found for β(2)m between 72 hours and baseline clearance. CONCLUSION: Polyacrylonitrile filters during continuous hemofiltration and continuous hemodialysis delivered at 35 ml/kg/h are comparable in little and middle size solute removal. CVVHD appears to warrant longer CRRT sessions. The capacity of both modalities for removing such molecules is maintained up to 48 hours. BioMed Central 2006 2006-04-28 /pmc/articles/PMC1550874/ /pubmed/16646985 http://dx.doi.org/10.1186/cc4903 Text en Copyright © 2006 Ricci et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Ricci, Zaccaria
Ronco, Claudio
Bachetoni, Alessandra
D'amico, Giuseppe
Rossi, Stefano
Alessandri, Elisa
Rocco, Monica
Pietropaoli, Paolo
Solute removal during continuous renal replacement therapy in critically ill patients: convection versus diffusion
title Solute removal during continuous renal replacement therapy in critically ill patients: convection versus diffusion
title_full Solute removal during continuous renal replacement therapy in critically ill patients: convection versus diffusion
title_fullStr Solute removal during continuous renal replacement therapy in critically ill patients: convection versus diffusion
title_full_unstemmed Solute removal during continuous renal replacement therapy in critically ill patients: convection versus diffusion
title_short Solute removal during continuous renal replacement therapy in critically ill patients: convection versus diffusion
title_sort solute removal during continuous renal replacement therapy in critically ill patients: convection versus diffusion
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1550874/
https://www.ncbi.nlm.nih.gov/pubmed/16646985
http://dx.doi.org/10.1186/cc4903
work_keys_str_mv AT riccizaccaria soluteremovalduringcontinuousrenalreplacementtherapyincriticallyillpatientsconvectionversusdiffusion
AT roncoclaudio soluteremovalduringcontinuousrenalreplacementtherapyincriticallyillpatientsconvectionversusdiffusion
AT bachetonialessandra soluteremovalduringcontinuousrenalreplacementtherapyincriticallyillpatientsconvectionversusdiffusion
AT damicogiuseppe soluteremovalduringcontinuousrenalreplacementtherapyincriticallyillpatientsconvectionversusdiffusion
AT rossistefano soluteremovalduringcontinuousrenalreplacementtherapyincriticallyillpatientsconvectionversusdiffusion
AT alessandrielisa soluteremovalduringcontinuousrenalreplacementtherapyincriticallyillpatientsconvectionversusdiffusion
AT roccomonica soluteremovalduringcontinuousrenalreplacementtherapyincriticallyillpatientsconvectionversusdiffusion
AT pietropaolipaolo soluteremovalduringcontinuousrenalreplacementtherapyincriticallyillpatientsconvectionversusdiffusion